Combining a Smartphone App With Medications to Manage Heavy Drinking

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
VA Office of Research and Development
Study ID
NCT06303778
Status
Recruiting

Conditions

  • Alcohol Use Disorder (AUD)

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Stand Down mobile app — OTHER
    The Stand Down mobile app is a smartphone-based stand-alone intervention designed to help persons manage drinking and alcohol-related problems on their own. The app is based on principles of motivational enhancement and cognitive-behavioral therapies and comprises 7 modules organized around 4 goals: (i) Enhance awareness of drinking patterns (assessment and personalized feedback), (ii) Establish and monitor progress towards drinking goal - i.e., moderation or abstinence, (iii) Manage cravings and other problems using in-the-moment tools, and (iv) Connect users with other types of support.
  • Standard Care — OTHER
    Participants assigned to the standard care condition will receive standard MAUD care delivered by their CPSs and will not receive access to SD-App. Three medications, naltrexone, disulfiram, and acamprosate, have been approved by the Federal Drug Administration and topiramate has been recommended by the VA/DoD clinical practice guidelines for SUD. MAUD includes these four medications. All medication decisions will be between the CPS and the Veteran and not influenced by study participation.

Study Details

One in 10 Veterans have an alcohol use disorder. However, few Veterans receive evidenced-based psychosocial interventions or medications to treat alcohol use disorder. Barriers to receiving these treatments include long wait times, stigma, and long distances from treatment facilities. Even fewer Veterans receive psychosocial and medication interventions together, despite clinical practice guidelines recommending both and evidence of better outcomes. Expanding access to these treatments in primary care is a VA priority but delivering psychosocial interventions is difficult in this setting, and medication is often the only option. Smartphone apps that deliver alcohol interventions may improve drinking outcomes and ensure Veterans can receive both treatments in primary care. This study will determine whether medications and an app for alcohol use problems offered to Veterans in primary care results in improved drinking outcomes, compared to Veterans receiving medications only. Study data will inform how to spread the app across the VA nationally.

Key Dates

Start date
Nov 1, 2024
Status verified
Oct 2025
Primary completion
Nov 1, 2028
Completion
Nov 1, 2028

Study Design

Enrollment
330 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Active Comparator: Standard Care
    Participants assigned to the standard care condition will receive standard MAUD care delivered by their CPSs and will not receive access to SD-App. Three medications, naltrexone, disulfiram, and acamprosate, have been approved by the Federal Drug Administration and topiramate has been recommended by the VA/DoD clinical practice guidelines for SUD. MAUD includes these four medications. All medication decisions will be between the CPS and the Veteran and not influenced by study participation.
  • Experimental: Combined MAUD+SD-App
    In addition to standard MAUD care, participants assigned to the MAUD+SD-App condition will receive access to the Stand Down app at randomization.

Primary Outcome Measure

Change in Percent Heavy Drinking Days [ Time Frame: 6 months post-baseline ]

Central Contacts

Locations (15)

FacilityCityStateZIPSite coordinators
Phoenix VA Health Care System, Phoenix, AZPhoenixArizona85012
Anissa Danner, MSW
Veterans Health Care System of the Ozarks, Fayetteville, ARFayettevilleArkansas72703-1944
Anissa Danner, MSW
Washington DC VA Medical Center, Washington, DCWashington D.C.District of Columbia20422-0001
Anissa Danner, MSW
North Florida/South Georgia Veterans Health System, Gainesville, FLGainesvilleFlorida32608-1135
Anissa Danner, MSW
Atlanta VA Medical and Rehab Center, Decatur, GADecaturGeorgia30033-4004
Anissa Danner, MSW
Carl Vinson VA Medical Center, Dublin, GADublinGeorgia31021
Anissa Danner, MSW
Battle Creek VA Medical Center, Battle Creek, MIBattle CreekMichigan49037
Anissa Danner, MSW
Minneapolis VA Health Care System, Minneapolis, MNMinneapolisMinnesota55417-2309
Anissa N Danner, MSW BA
(206) 277-4878
Hildi J. Hagedorn, PhD (SUB_INVESTIGATOR)
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NEOmahaNebraska68105-1850
Anissa Danner, MSW
Tennessee Valley Healthcare System Nashville Campus, Nashville, TNNashvilleTennessee37212-2637
Anissa Danner, MSW
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TXDallasTexas75216-7167
Anissa Danner, MSW
South Texas Health Care System, San Antonio, TXSan AntonioTexas78229-4404
Anissa Danner, MSW
VA Salt Lake City Health Care System, Salt Lake City, UTSalt Lake CityUtah84148-0001
Anissa Danner, MSW
Richmond VA Medical Center, Richmond, VARichmondVirginia23249-0001
Anissa Danner, MSW
VA Puget Sound Health Care System Seattle Division, Seattle, WASeattleWashington98108-1532
Thomas S Bundt, FACHE
(253) 583-3500
Susan Perez, BA
(202) 461-6910
Eric J. Hawkins, PhD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Phoenix, AZ

Related Studies